Top

Published in:

01-09-2016 | Review

Complex roles of NRAGE on tumor

Authors: Ge Zhang, Huandi Zhou, Xiaoying Xue

Published in: Tumor Biology | Issue 9/2016

Abstract

NRAGE, also known as Dlxin-1or MAGE-D1, is a member of type II melanoma-associated antigen (MAGE) and plays an essential role in life activities, including differentiation, apoptosis, and cell cycle. Studies increasingly found that NRAGE is closely related to the tumor events, such as tumor occurrence, invasion, and metastasis. However, complex and contradictory functions of NRAGE in different circumstances are observed, suggesting that NRAGE is unique from other MAGE gene family members. This review summarizes recent findings concerning the structure and biological functions of NRAGE, which may provide a basis for a more comprehensive understanding of and further research on NRAGE.

Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S. An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 2001;61(14):5544–51.PubMed

Clotman F, De Backer O, De Plaen E, Boon T, Picard J. Cell- and stage-specific expression of mage genes during mouse spermatogenesis. Mamm Genome. 2000;11(8):696–9.CrossRefPubMed

Lucas S, Brasseur F, Boon T. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res. 1999;59(16):4100–3.PubMed

Barker PA, Salehi A. The MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res. 2002;67(6):705–12.CrossRefPubMed

Hennuy B, Reiter E, Cornet A, Bruyninx M, Daukandt M, Houssa P, et al. A novel messenger ribonucleic acid homologous to human MAGE-D is strongly expressed in rat Sertoli cells and weakly in Leydig cells and is regulated by Follitropin, lutropin, and prolactin1. Endocrinology. 2000;141(10):3821–31.PubMed

Põld M, Zhou J, Chen GL, Hall JM, Vescio RA, Berenson JR. Identification of a new, unorthodox member of the MAGE gene family. Genomics. 1999;59(2):161–7.CrossRefPubMed

Masuda Y, Sasaki A, Shibuya H, Ueno N, Ikeda K, Watanabe K. Dlxin-1, a novel protein that binds Dlx5 and regulates its transcriptional function. J Biol Chem. 2001;276(7):5331–8.CrossRefPubMed

Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, et al. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron. 2000;27(2):279–88.CrossRefPubMed

Rochira JA, Matluk NN, Adams TL, Karaczyn AA, Oxburgh L, Hess ST, et al. A small peptide modeled after the NRAGE repeat domain inhibits XIAP-TAB1-TAK1 signaling for NF-kB activation and apoptosis in P19 cells. PLoS ONE. 2011;6(7), e20659.CrossRefPubMedPubMedCentral

10.

Matluk N, Rochira JA, Karaczyn A, Adams T, Verdi JM. A role for NRAGE in NF-kB activation through the non-canonical BMP pathway. BMC Biol. 2010;8(1):7.CrossRefPubMedPubMedCentral

11.

Rochira JA, Cowling RA, Himmelfarb JS, Adams TL, Verdi JM. Mapping of NRAGE domains reveals clues to cell viability in BMP signaling. Apoptosis. 2010;15(1):63–70.CrossRefPubMedPubMedCentral

12.

Lebrun-Julien F, Bertrand MJ, De Backer O, Stellwagen D, Morales CR, Di Polo A, et al. ProNGF induces TNF -dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proc Nat Acad Sci. 2010;107(8):3817–22.CrossRefPubMedPubMedCentral

13.

Nikopoulos GN, Martins JF, Adams TL, Karaczyn A, Adams D, Vary C, et al. NRAGE: a potential rheostat during branching morphogenesis. Mech Dev. 2009;126(5-6):337–49.CrossRefPubMedPubMedCentral

14.

Bertrand MJM, Kenchappa RS, Andrieu D, Leclercq-Smekens M, Nguyen HNT, Carter BD, et al. NRAGE, a p75NTR adaptor protein, is required for developmental apoptosis in vivo. Cell Death Differ. 2008;15(12):1921–9.CrossRefPubMedPubMedCentral

15.

Di Certo MG, Corbi N, Bruno T, Iezzi S, De Nicola F, Desantis A, et al. NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death. J Cell Sci. 2007;120(11):1852–8.CrossRefPubMed

16.

Salehi AH, Morris SJ, Ho W, Dickson KM, Doucet G, Milutinovic S, et al. AEG3482 is an antiapoptotic compound that inhibits Jun kinase activity and cell death through induced expression of heat shock protein 70. Chem Biol. 2006;13(2):213–23.CrossRefPubMed

17.

Kendall SE, Battelli C, Irwin S, Mitchell JG, Glackin CA, Verdi JM. NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade. Mol Cell Biol. 2005;25(17):7711–24.CrossRefPubMedPubMedCentral

18.

Williams ME, Strickland P, Watanabe K, Hinck L. UNC5H1 induces apoptosis via its juxtamembrane region through an interaction with NRAGE. J Biol Chem. 2003;278(19):17483–90.CrossRefPubMed

19.

Salehi AH, Xanthoudakis S, Barker PA. NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway. J Biol Chem. 2002;277(50):48043–50.CrossRefPubMed

20.

Jordan BWM, Dinev D, LeMellay V, Troppmair J, Gotz R, Wixler L, et al. Neurotrophin receptor-interacting mage homologue is an inducible inhibitor of apoptosis protein-interacting protein that augments cell death. J Biol Chem. 2001;276(43):39985–9.CrossRefPubMed

21.

Teuber J, Mueller B, Fukabori R, Lang D, Albrecht A, Stork O. The ubiquitin ligase Praja1 reduces NRAGE expression and inhibits neuronal differentiation of PC12 cells. PLoS ONE. 2013;8(5), e63067.CrossRefPubMedPubMedCentral

22.

Nguyen TH, Bertrand MJ, Sterpin C, Achouri Y, De Backer OR. Maged1, a new regulator of skeletal myogenic differentiation and muscle regeneration. BMC Cell Biol. 2010;11(1):57.CrossRefPubMedPubMedCentral

23.

Feng Z, Li K, Liu M, Wen C. NRAGE is a negative regulator of nerve growth factor-stimulated neurite outgrowth in PC12 cells mediated through TrkA-ERK signaling. J Neurosci Res 2010: NA-NA.

24.

Kuwajima T. Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. J Neurosci. 2006;26(20):5383–92.CrossRefPubMed

25.

Bertrand M, Huijbers I, Chomez P, De Backer O. Comparative expression analysis of theMAGED genes during embryogenesis and brain development. Dev Dyn. 2004;230(2):325–34.CrossRefPubMed

26.

Kuwajima T. Necdin interacts with the Msx2 homeodomain protein via MAGE-D1 to promote myogenic differentiation of C2C12 cells. J Biol Chem. 2004;279(39):40484–93.CrossRefPubMed

27.

Sasaki A. A RING finger protein Praja1 regulates Dlx5-dependent transcription through its ubiquitin ligase activity for the Dlx/Msx-interacting MAGE/necdin family protein, dlxin-1. J Biol Chem. 2002;277(25):22541–6.CrossRefPubMed

28.

Wang X, Tang J, Xing L, Shi G, Ruan H, Gu X, et al. Interaction of MAGED1 with nuclear receptors affects circadian clock function. EMBO J. 2010;29(8):1389–400.CrossRefPubMedPubMedCentral

29.

Mouri A, Sasaki A, Watanabe K, Sogawa C, Kitayama S, Mamiya T, et al. MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation. J Neurosci. 2012;32(13):4562–80.CrossRefPubMed

30.

Dombret C, Nguyen T, Schakman O, Michaud JL, Hardin-Pouzet H, Bertrand MJM, et al. Loss of Maged1 results in obesity, deficits of social interactions, impaired sexual behavior and severe alteration of mature oxytocin production in the hypothalamus. Hum Mol Genet. 2012;21(21):4703–17.CrossRefPubMed

31.

Silva MMCD, Gil LHVG, Marques Junior ETDA, Calzavara-Silva CE. Potential biomarkers for the clinical prognosis of severe dengue. Memórias do Instituto Oswaldo Cruz. 2013;108(6):755–62.CrossRefPubMedPubMedCentral

32.

Yang J, Lai B, Xu A, Liu Y, Li X, Zhao Y, et al. Maged1 co-interacting with CREB through a hexapeptide repeat domain regulates learning and memory in mice. Mol Neurobiol. 2015;51(1):8–18.CrossRefPubMed

33.

Shen W, Xue Q, Zhu J, Hu B, Zhang Y, Wu Y, et al. Inhibition of adenovirus-mediated human MAGE-D1 on angiogenesis in vitro and in vivo. Mol Cell Biochem. 2007;300(1-2):89–99.CrossRefPubMed

34.

Kang J, Chung KC. The F-box protein FBXO7 positively regulates bone morphogenetic protein-mediated signaling through Lys-63-specific ubiquitination of neurotrophin receptor-interacting MAGE (NRAGE). Cell Mol Life Sci. 2015;72(1):181–95.CrossRefPubMed

35.

Yang Q, Ou C, Liu M, Xiao W, Wen C, Sun F. NRAGE promotes cell proliferation by stabilizing PCNA in a ubiquitin-proteasome pathway in esophageal carcinomas. Carcinogenesis. 2014;35(7):1643–51.CrossRefPubMed

36.

Lee D, Lee GK, Yoon K, Lee JS. Pathway-based analysis using genome-wide association data from a Korean non-small cell lung cancer study. PloS one. 2013;8(6), e65396.CrossRefPubMedPubMedCentral

37.

Lai S, Xue B, Yang Y, Zhao L, Chu C, Hao J, et al. Ror2-Src signaling in metastasis of mouse melanoma cells is inhibited by NRAGE. Cancer Genetics. 2012;205(11):552–62.CrossRefPubMed

38.

Kumar S, Park SH, Cieply B, Schupp J, Killiam E, Zhang F, et al. A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition. Mol Cell Biol. 2011;31(19):4036–51.CrossRefPubMedPubMedCentral

39.

Fussbroich B, Wagener N, Macher-Goeppinger S, Benner A, Fälth M, Sültmann H, et al. EZH2 depletion blocks the proliferation of colon cancer cells. PLoS ONE. 2011;6(7), e21651.CrossRefPubMedPubMedCentral

40.

Reddy EM, Chettiar ST, Kaur N, Ganeshkumar R, Shepal V, Shanbhag NC, et al. Dlxin-1, a member of MAGE family, inhibits cell proliferation, invasion and tumorigenicity of glioma stem cells. Cancer Gene Ther. 2010;18(3):206–18.CrossRefPubMed

41.

Xue XY, Liu ZH, Jing FM, Li YG, Liu HZ, Gao XS. Relationship between NRAGE and the radioresistance of esophageal carcinoma cell line TE13R120. Chin J Cancer. 2010;29(10):900–6.CrossRefPubMed

42.

Du Q, Zhang Y, Tian X, Li Y, Fang W. MAGE-D1 inhibits proliferation, migration and invasion of human breast cancer cells. Oncol Rep. 2009;22(3):659–65.PubMed

43.

Shen W, Xue Q, Wu Y, Hu B, Zhu J, Zhang Y, et al. Melanoma-associated antigen family protein-D1 regulation of tumor cell migration, adhesion to endothelium, and actin structures reorganization in response to hypoxic stress. Cell Commun Adhes. 2007;14(1):21–31.CrossRefPubMed

44.

Chu C, Xue B, Tu C, Feng Z, Shi Y, Miao Y, et al. NRAGE suppresses metastasis of melanoma and pancreatic cancer in vitro and in vivo. Cancer Lett. 2007;250(2):268–75.CrossRefPubMed

45.

Tian XX. BRCA2 suppresses cell proliferation via stabilizing MAGE-D1. Cancer Res. 2005;65(11):4747–53.CrossRefPubMedPubMedCentral

46.

Xue B, Wen C, Shi Y, Zhao D, Li C. Human NRAGE disrupts E-cadherin/β-catenin regulated homotypic cell–cell adhesion. Biochem Biophys Res Commun. 2005;336(1):247–51.CrossRefPubMed

47.

Wen C, Xue B, Qin W, Yu M, Zhang M, Zhao D, et al. hNRAGE, a human neurotrophin receptor interacting MAGE homologue, regulates p53 transcriptional activity and inhibits cell proliferation. FEBS Lett. 2004;564(1-2):171–6.CrossRefPubMed

48.

Reddy EM, Chettiar ST, Kaur N, Shepal V, Shiras A. Dlxin-1, a MAGE family protein, induces accelerated neurite outgrowth and cell survival by enhanced and early activation of MEK and Akt signalling pathways in PC12 cells. Exp Cell Res. 2010;316(14):2220–36.CrossRefPubMed

49.

Cheng C, Huang X, Ding Y, Zang W, Zhang Q. Effect of shRNA against NRAGE gene on proliferation and apoptosis of SGC7901 cells. J Zhengzhou Univ (Medical Sciences). 2008;43(2):304–6.

50.

Passananti C, Fanciulli M. The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response. Cell Div. 2007;2(1):21.CrossRefPubMedPubMedCentral

51.

Bragason BT, Palsdottir A. Interaction of PrP with NRAGE, a protein involved in neuronal apoptosis. Mol Cell Neurosci. 2005;29(2):232–44.CrossRefPubMed

52.

Wu Q, Qi S, Ma J, Chen F, Chen J, Li J, et al. The effect of NRAGE on cell cycle and apoptosis of human dental pulp cells and MDPC-23. Int J Clin Exp Med. 2015;8(7):10657–67.PubMedPubMedCentral

53.

Zhou L, Xue B, Guo S, Shi Y, Wen C, Li C. Construction of recombinant adenovirus vector of hNRAGE gene and its effect on cell cycle of 293 cells. Chin J Cell Mol Immunol. 2006;22(01):18–21.

54.

Xue X, Gao X, Zhou Z, Zhang P, Lu F, Duan H. A study of the relationship of the radioresistance of esophageal carcinoma cell line TE13R120 with HDAC3, NF-kB and NRAGE. Chin J Radiol Med Protecion. 2005;25(1):27–30.

55.

Zhang Z, Yan A, Zhang Z, Luo D. Expression of NRAGE gene in gastric carcinoma and its regulation role in apoptosis. J Med Forum. 2007;28(19):17–8.

56.

Matsuda T, Suzuki H, Oishi I, Kani S, Kuroda Y, Komori T, et al. The receptor tyrosine kinase Ror2 associates with the melanoma-associated antigen (MAGE) family protein dlxin-1 and regulates its intracellular distribution. J Biol Chem. 2003;278(31):29057–64.CrossRefPubMed

57.

Zhou H, Zhang G, Xue X, Yang Y, Yang Y, Chang X, Ge X, Xiao Z, Guo H, Wang Y. Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells. Tumour Biol 2016.

Title: Complex roles of NRAGE on tumor
Authors: Ge Zhang
Huandi Zhou
Xiaoying Xue
Publication date: 01-09-2016
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 9/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-016-5084-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2016

The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion

Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2

EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway

p16 upregulation is linked to poor prognosis in ERG negative prostate cancer

Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation

A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells

Keynote webinar | Spotlight on antibody–drug conjugates in cancer